microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft prolia® denosumab × indications prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal read more prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal women with osteoporosis prolia® reduces the incidence of vertebral nonvertebral and hip fractures prolia® is indicated for treatment to increase bone mass in men with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy prolia® is indicated as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer in these patients prolia® also reduced the incidence of vertebral fractures prolia® is indicated as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer close prescribing information medication guide important safety information nonus residents for patients indications rems search postmenopausal osteoporosis male osteoporosis cancer treatment—induced bone loss how to get prolia® toggle menu menu postmenopausal osteoporosis pmo pmo overview patient identification treatment naive risk factors for fracture intolerant to other osteoporosis therapy failed other therapy prior fracture prevalence treatment prevalence vertebral fracture risk subsequent fracture risk hip fracture risk women over the age of  study design pivotal efficacy fracture risk reduction increase in bmd safety adverse reactions pivotal trial dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe male osteoporosis male op male osteoporosis male op overview patient identification risk factors among men assessment recommendations height loss prevalence risk assessment is rare osteoporosis prevalence study design pivotal efficacy lumbar spine bmd total hip bmd dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe cancer treatment–induced bone loss ctibl breast cancer treatment–induced bone loss ctibl overview bmd data ctiblhalt pivotal trial fracture reduction data abcsg study prostate cancer treatment–induced bone loss ctibl overview bmd and fracture reduction data pivotal trial if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe how to get prolia® how to get prolia® overview fulfillment options verify coverage financial assistance injection reminder coding and billing insurance coverage medicare part b cost medicare part b coverage medicare part d cost medicare part d coverage commercial coverage copay and financial assistance prolia® copay card medicaremedicaid referrals uninsuredunderinsured options support program insurance support treatment reminders financial assistance referral for ctiblhalt patients for ctiblhalt patients amgen assist ™ if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe helpful links  resources helpful links  resources amgen resources preferred distributors educational resources patient identification videos nonus residents important safety information for patients rems for the treatment of postmenopausal women with osteoporosis at high risk for fracture with  dose every  months prolia® follows your pmo patients all year long  mg subcutaneous injection in the upper arm upper thigh or abdomen by a healthcare professional preexisting hypocalcemia must be corrected prior to initiating therapy with prolia® adequately supplement all patients with calcium and vitamin d multiple vertebral fractures have been reported following prolia® discontinuation risk evaluation and mitigation strategy rems learn about coverage and multiple fulfillment solutions available for your prolia® patients how to get prolia®  i frequently get a sour taste in my mouth  i regularly feel a burning pain in my throat  i often get heartburn what are you hearing from your patients with pmo at high risk for fracture this image is for illustration purposes only patient types  if she had a prior fracture is she at risk of another fracture ask your pmo patients if they’ve had a prior osteoporotic fracture in women prior osteoporotic fracture increases the relative risk of a subsequent fracture by  this image is for illustration purposes only patient types falling excessive thinness cigarette smoking advanced age prior fracture as an adult parental history of hip fracture are there pmo patients with multiple risk factors for fracture in your practice  or more risk factors put your postmenopausal osteoporotic patients at high risk for fracture patient types tscore at therapy start  tscore at  years  tscore at  years  do you have pmo patients with a significant bmd decline despite osteoporosis therapy whom you consider a treatment failure this image is for illustration purposes only patient types  in  women over the age of  will have a fracture related to osteoporosis in their lifetime take a closer look at fracture risk and prevalence among women with postmenopausal osteoporosis prevalence for the treatment of postmenopausal women with osteoporosis at high risk for fracture prolia® is proven to significantly reduce fracture risk at  years at vertebral hip and nonvertebral sites in the pivotal phase  fracture trial vs placebo n   efficacy please see efficacy section for important study details prolia® was studied for  years in a pivotal phase  fracture trial of  women with postmenopausal osteoporosis study design important safety information clinically significant hypersensitivity including anaphylaxis has been reported with prolia® if an anaphylactic or other clinically significant allergic reaction occurs initiate appropriate therapy and discontinue prolia® prolia® denosumab safety profile learn about adverse reactions reported in women with pmo from the pivotal phase  fracture trial adverse reactions learn about the prolia® risk evaluation and mitigation strategy program rems learn about prolia® important safety information important safety information prolia® is  shot every  months singleuse prefilled  ml syringe  mg subcutaneous injection in the upper arm upper thigh or abdomen by a healthcare professional preexisting hypocalcemia must be corrected prior to initiating therapy with prolia® adequately supplement all patients with calcium and vitamin d multiple vertebral fractures have been reported following prolia® discontinuation as a subcutaneous injection prolia® does not undergo firstpass metabolism may lessen patient pill burden dosing important safety information following discontinuation of prolia® treatment fracture risk increases including the risk of multiple vertebral fractures evaluate an individual’s benefitrisk before initiating treatment with prolia® if prolia® treatment is discontinued consider transitioning to an alternative antiresorptive therapy see how prolia® works as the first fdaapproved rank ligand inhibitor for pmo patients at high risk for fracture learn more help your patients get prolia® prolia® has confirmed medical benefit coverage nationwide you can administer prolia® in your office or refer your patient to an injection center coverage × × you are now leaving proliahcpcom you are now leaving proliahcpcom please know that the sponsors of this site are not responsible for content on the site you are about to enter please click here to continue 😳 you currently have javscript disabled this site is best viewed with javscript enabled 😳 prolia® denosumab  insurance coverage × indications prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal read more prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal women with osteoporosis prolia® reduces the incidence of vertebral nonvertebral and hip fractures prolia® is indicated for treatment to increase bone mass in men with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy prolia® is indicated as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer in these patients prolia® also reduced the incidence of vertebral fractures prolia® is indicated as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer close prescribing information medication guide important safety information nonus residents for patients indications rems search postmenopausal osteoporosis male osteoporosis cancer treatment—induced bone loss how to get prolia® toggle menu menu postmenopausal osteoporosis pmo pmo overview patient identification treatment naive risk factors for fracture intolerant to other osteoporosis therapy failed other therapy prior fracture prevalence treatment prevalence vertebral fracture risk subsequent fracture risk hip fracture risk women over the age of  study design pivotal efficacy fracture risk reduction increase in bmd safety adverse reactions pivotal trial dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe male osteoporosis male op male osteoporosis male op overview patient identification risk factors among men assessment recommendations height loss prevalence risk assessment is rare osteoporosis prevalence study design pivotal efficacy lumbar spine bmd total hip bmd dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe cancer treatment–induced bone loss ctibl breast cancer treatment–induced bone loss ctibl overview bmd data ctiblhalt pivotal trial fracture reduction data abcsg study prostate cancer treatment–induced bone loss ctibl overview bmd and fracture reduction data pivotal trial if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe how to get prolia® how to get prolia® overview fulfillment options verify coverage financial assistance injection reminder coding and billing insurance coverage medicare part b cost medicare part b coverage medicare part d cost medicare part d coverage commercial coverage copay and financial assistance prolia® copay card medicaremedicaid referrals uninsuredunderinsured options support program insurance support treatment reminders financial assistance referral for ctiblhalt patients for ctiblhalt patients amgen assist ™ if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe helpful links  resources helpful links  resources amgen resources preferred distributors educational resources patient identification videos nonus residents important safety information for patients rems how to get prolia® coverage prolia® is broadly covered by medicare and commercial health plans nationwide†  coverage for medicare part b†  coverage for medicare part d†  coverage for commercial plans† please see planspecific requirements †medicare part b data as of february  medicare part d for the treatment in postmenopausal women with osteoporosis at high risk for fracture prescription drug plans covering  of part d beneficiaries include prolia® on their formularies policies for the remaining  of beneficiaries were not reviewed commercial based on analysis of coverage under the medical benefits of  us commercial plans for  million targeted commercial lives data as of february   medicare part b medicare part d commercial plans medicare part b  of prolia® syringes cost medicare part b patients  oop according to benefit verification data†‡ oop costs for medicare part b patients per prolia® syringe  of syringes these data do not include medical benefit oop costs related to office visits or administration of prolia® this sample includes medicare patients with supplementalsecondary coverage eg medigap that may require additional monthly premiums individual oop costs will vary data reflect insurance verifications for medicare part b patients only n   not actual claims completed by proliaplus® from january   to december   †oop costs identified in insurance verification data as a percentage eg coinsurance were converted to dollars using the medicare part b reimbursement rate for q  which was  ‡costs for patients covered by medicare part c medicare advantage vary by plan the cost information provided is for informational purposes only policies change periodically and often without warning if you have questions about oop costs contact the payer  of medicare part b beneficiaries have prolia® coverage with no prior authorization required all medicare administrative contractors cover prolia® there are no prior authorizations under medicare part b† pa may be required under medicare part c medicare advantage‡ prolia® has confirmed medical benefit coverage nationwide data as of february  †individual plans may request documentation to confirm administration is consistent with the prolia® label ‡ of patients covered by medicare part c medicare advantage plans require prior authorization data reflect insurance verifications for medicare part c medicare advantage patients n   not actual claims completed by proliaplus® from january   to december   verify your patients insurance coverage with proliaplus® our support program can refer eligible medicare part b and medicare part d patients to independent copay foundations which may be able to provide financial assistance explore proliaplus® learn about financial assistance medicare part d approximately  of prolia® syringes cost medicare part d patients no more than  out of pocket oop oop costs for medicare part d patients per prolia® syringe  of syringes for  of medicare part d patients with a copay less than  per syringe the approximate cost is  per month these pharmacy claims data do not include deductibles or any other physicianrelated service fees associated with administration of prolia® eg doctor visits oop costs may vary by patient andor injection data reflect ims formulary impact analyzer prolia® medicare part d claims n january  to september  data from commercial patients were not included in these analyses the cost information provided is for informational purposes only policies change periodically and often without warning if you have questions about oop costs contact the payer  of medicare part d beneficiaries have coverage for prolia® over half with no prior authorization pa required† prolia® has confirmed medical benefit coverage nationwide prolia® is covered by the following top† medicare part d plans aetnacoventry no pa required anthemblue cross blue shield affiliates  cignahealthspring no pa required‡ cvs caremarksilverscripthealth net no pa required express scripts pa may be required§ humana no pa required prime therapeuticsmedicareblue rxbluerx pa may be required¶ rite aidenvisionrx no pa required united healthcareaarpoptumrx  wellcare no pa required for the treatment in postmenopausal women with osteoporosis at high risk for fracture prescription drug plans covering  of part d beneficiaries include prolia® on their formularies policies for the remaining  of beneficiaries were not reviewed †plans are listed in alphabetical order list includes top plans based on covered lives that cover prolia® ‡plan requires an electronic step edit §some plans under express scripts may require a pa ¶medicareblue rx representing bcbs of mn mt ne nd and wy does not require a pa blue cross medicarerx representing bcbs of il nm ok and tx requires a pa other blue plans affiliated with prime therapeutics may or may not require a pa the coverage information provided is for informational purposes only and should in no way be considered a guarantee of coverage or reimbursement for any product or service policies change periodically and often without warning the responsibility to determine coverage and reimbursement parameters for a particular patient is always the responsibility of the provider or physician verify your patients insurance coverage with proliaplus® our support program can refer eligible medicare part b and medicare part d patients to independent copay foundations which may be able to provide financial assistance explore proliaplus® learn about financial assistance medicare provides coverage of dxa scans for women identified by a physician as estrogen deficient and at clinical risk of osteoporosis women and men with vertebral abnormalities indicative of osteoporosis and vertebral fracture women and men currently receiving an fdaapproved medication for osteoporosis commercial  oop cost with the prolia® copay card eligible patients with commercial insurance can pay  or less explore financial assistance commercially insured lives with medical benefit coverage for prolia®  have commercial coverage with policy language more restrictive than fdaapproved indication‡ approximately  of commercially insured prolia® patients did not require prior authorization data reflect insurance verifications n not actual claims for commercially insured patients submitted to and completed by proliaplus® in  plans may require that patient either fails or is intolerant to another osteoporosis medication please see planspecific requirements †based on analysis of coverage under the medical benefits of  us commercial plans for  million targeted commercial lives data as of february   ‡for example multiple bisphosphonate trials or limited inclusion criteria verify your patients insurance coverage with proliaplus® our support program can help verify patient coverage and outofpocket costs for prolia®—with results sent directly to your office explore proliaplus® learn about financial assistance × you are now leaving proliahcpcom you are now leaving proliahcpcom please know that the sponsors of this site are not responsible for content on the site you are about to enter please click here to continue 😳 you currently have javscript disabled this site is best viewed with javscript enabled 😳 how to get prolia® denosumab × indications prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal read more prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal women with osteoporosis prolia® reduces the incidence of vertebral nonvertebral and hip fractures prolia® is indicated for treatment to increase bone mass in men with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy prolia® is indicated as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer in these patients prolia® also reduced the incidence of vertebral fractures prolia® is indicated as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer close prescribing information medication guide important safety information nonus residents for patients indications rems search postmenopausal osteoporosis male osteoporosis cancer treatment—induced bone loss how to get prolia® toggle menu menu postmenopausal osteoporosis pmo pmo overview patient identification treatment naive risk factors for fracture intolerant to other osteoporosis therapy failed other therapy prior fracture prevalence treatment prevalence vertebral fracture risk subsequent fracture risk hip fracture risk women over the age of  study design pivotal efficacy fracture risk reduction increase in bmd safety adverse reactions pivotal trial dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa read more about icd and jcode information learn more male osteoporosis male op male osteoporosis male op overview patient identification risk factors among men assessment recommendations height loss prevalence risk assessment is rare osteoporosis prevalence study design pivotal efficacy lumbar spine bmd total hip bmd dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa read more about icd and jcode information learn more cancer treatment–induced bone loss ctibl breast cancer treatment–induced bone loss ctibl overview bmd data ctiblhalt pivotal trial fracture reduction data abcsg study prostate cancer treatment–induced bone loss ctibl overview bmd and fracture reduction data pivotal trial read more about icd and jcode information learn more how to get prolia® how to get prolia® overview fulfillment options verify coverage financial assistance injection reminder coding and billing insurance coverage medicare part b cost medicare part b coverage medicare part d cost medicare part d coverage commercial coverage copay and financial assistance prolia® copay card medicaremedicaid referrals uninsuredunderinsured options support program insurance support treatment reminders financial assistance referral for ctiblhalt patients for ctiblhalt patients amgen assist ™ read more about icd and jcode information learn more helpful links  resources helpful links  resources amgen resources preferred distributors educational resources patient identification videos nonus residents important safety information for patients rems coverage information and fullfillment options to help your patients get prolia®  medicare part b coverage  medicare part d coverage  commercial coverage choose your fulfillment channel below as the first step in deciding how to get prolia® medicare part b data as of february  medicare part d for the treatment in postmenopausal women with osteoporosis at high risk for fracture prescription drug plans covering  of part d beneficiaries include prolia® on their formularies policies for the remaining  of beneficiaries were not reviewed commercial based on analysis of coverage under the medical benefits of  us commercial plans for  million targeted commercial lives data as of february   learn about coverage and outofpocket costs for prolia® explore coverage choose how to help your patients get prolia® buy and bill for inoffice injections you can buy prolia® and deliver injections in your own office even for patients on medicare part b refer patients to injection sites you can refer your patients to a healthcare facility to receive their prolia® injection fill prescription through pharmacy specialty or retail pharmacies can fill prolia® prescriptions including those for patients with medicare part d read more about icd and jcode information below read more connect with preferred distributors to order prolia® for your office directly from one of our preferred distributors browse our helpful links page for a list of contact information and credit applications find preferred distributors verify your patients’ insurance coverage you can also learn how proliaplus® can help verify patient coverage and outofpocket costs for prolia® with results sent directly to your office explore insurance support explore prolia® injection network locations† to refer your patients to a healthcare facility to receive their prolia® injection you can explore our searchable prolia® injection network locations database explore injection networks verify your patients’ insurance coverage you can also learn how proliaplus® can help verify patient coverage and outofpocket costs for prolia® with results sent directly to your office explore insurance support †any listing of injection network sites is for informational purposes only and should not be considered a comprehensive list of all the sites in a particular area in addition use of a site identified on the list does not guarantee coverage or administration of prolia® and does not guarantee that a particular patient will be administered or covered for prolia® find a specialty or local pharmacy to connect patients with specialty or local retail pharmacies to fill their prolia® prescriptions explore our searchable pharmacy database find a pharmacy explore fulfillment through specialty pharmacies specialty pharmacies can provide coordinated delivery and services to help prolia® patients start and stay on therapy these additional services may include insurance coverage investigation and prior authorization process support next injection reminders and prescription refills some health plans require a specific specialty pharmacy to be used mandated specialty pharmacies see your patient’s plan for specific policies instructions and requirements download mandated specialty pharmacies learn how to help patients find support and explore their financial assistance options connect with patient support explore financial assistance schedule next injection appointments for prolia® patients in your office singleuse prefilled  ml syringe this image is for illustration purposes only and represents a snapshot in time actual dosing and duration of a particular patients therapy should be based upon the products approved labeling and the independent clinical decision of the provider schedule your patient’s injection appointments every  months and learn about treatment reminders for your patients and your practice learn about treatment reminders prolia® is administered as  shot every  months  mg subcutaneous injection in the upper arm upper thigh or abdomen by a healthcare professional preexisting hypocalcemia must be corrected prior to initiating therapy with prolia® adequately supplement all patients with calcium and vitamin d multiple vertebral fractures have been reported following prolia® discontinuation coding and billing information on average prolia® claims are paid by medicare within  days‡ the permanent jcode for prolia® for medicare claim processing j injection denosumab  mg icd codes some payers may require providers to include icdcm diagnosis codes on medical claims for prolia® learn about examples of icd codes that may be appropriate for your patients read more ‡based on analysis of  medicare claims from january  to october  for prolia® includes claims paid on the first submission any information is of general nature only and not intended to be directive or a guarantee of reimbursement coding billing and coverage policies change periodically and often without warning the responsibility to determine coverage and reimbursement parameters—and appropriate coding for a particular partient andor procedure—is always the responsibility of the provider or physician × you are now leaving proliahcpcom you are now leaving proliahcpcom please know that the sponsors of this site are not responsible for content on the site you are about to enter please click here to continue 😳 you currently have javscript disabled this site is best viewed with javscript enabled 😳 prolia® denosumab  insurance coverage × indications prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal read more prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal women with osteoporosis prolia® reduces the incidence of vertebral nonvertebral and hip fractures prolia® is indicated for treatment to increase bone mass in men with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy prolia® is indicated as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer in these patients prolia® also reduced the incidence of vertebral fractures prolia® is indicated as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer close prescribing information medication guide important safety information nonus residents for patients indications rems search postmenopausal osteoporosis male osteoporosis cancer treatment—induced bone loss how to get prolia® toggle menu menu postmenopausal osteoporosis pmo pmo overview patient identification treatment naive risk factors for fracture intolerant to other osteoporosis therapy failed other therapy prior fracture prevalence treatment prevalence vertebral fracture risk subsequent fracture risk hip fracture risk women over the age of  study design pivotal efficacy fracture risk reduction increase in bmd safety adverse reactions pivotal trial dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe male osteoporosis male op male osteoporosis male op overview patient identification risk factors among men assessment recommendations height loss prevalence risk assessment is rare osteoporosis prevalence study design pivotal efficacy lumbar spine bmd total hip bmd dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe cancer treatment–induced bone loss ctibl breast cancer treatment–induced bone loss ctibl overview bmd data ctiblhalt pivotal trial fracture reduction data abcsg study prostate cancer treatment–induced bone loss ctibl overview bmd and fracture reduction data pivotal trial if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe how to get prolia® how to get prolia® overview fulfillment options verify coverage financial assistance injection reminder coding and billing insurance coverage medicare part b cost medicare part b coverage medicare part d cost medicare part d coverage commercial coverage copay and financial assistance prolia® copay card medicaremedicaid referrals uninsuredunderinsured options support program insurance support treatment reminders financial assistance referral for ctiblhalt patients for ctiblhalt patients amgen assist ™ if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe helpful links  resources helpful links  resources amgen resources preferred distributors educational resources patient identification videos nonus residents important safety information for patients rems how to get prolia® coverage prolia® is broadly covered by medicare and commercial health plans nationwide†  coverage for medicare part b†  coverage for medicare part d†  coverage for commercial plans† please see planspecific requirements †medicare part b data as of february  medicare part d for the treatment in postmenopausal women with osteoporosis at high risk for fracture prescription drug plans covering  of part d beneficiaries include prolia® on their formularies policies for the remaining  of beneficiaries were not reviewed commercial based on analysis of coverage under the medical benefits of  us commercial plans for  million targeted commercial lives data as of february   medicare part b medicare part d commercial plans medicare part b  of prolia® syringes cost medicare part b patients  oop according to benefit verification data†‡ oop costs for medicare part b patients per prolia® syringe  of syringes these data do not include medical benefit oop costs related to office visits or administration of prolia® this sample includes medicare patients with supplementalsecondary coverage eg medigap that may require additional monthly premiums individual oop costs will vary data reflect insurance verifications for medicare part b patients only n   not actual claims completed by proliaplus® from january   to december   †oop costs identified in insurance verification data as a percentage eg coinsurance were converted to dollars using the medicare part b reimbursement rate for q  which was  ‡costs for patients covered by medicare part c medicare advantage vary by plan the cost information provided is for informational purposes only policies change periodically and often without warning if you have questions about oop costs contact the payer  of medicare part b beneficiaries have prolia® coverage with no prior authorization required all medicare administrative contractors cover prolia® there are no prior authorizations under medicare part b† pa may be required under medicare part c medicare advantage‡ prolia® has confirmed medical benefit coverage nationwide data as of february  †individual plans may request documentation to confirm administration is consistent with the prolia® label ‡ of patients covered by medicare part c medicare advantage plans require prior authorization data reflect insurance verifications for medicare part c medicare advantage patients n   not actual claims completed by proliaplus® from january   to december   verify your patients insurance coverage with proliaplus® our support program can refer eligible medicare part b and medicare part d patients to independent copay foundations which may be able to provide financial assistance explore proliaplus® learn about financial assistance medicare part d approximately  of prolia® syringes cost medicare part d patients no more than  out of pocket oop oop costs for medicare part d patients per prolia® syringe  of syringes for  of medicare part d patients with a copay less than  per syringe the approximate cost is  per month these pharmacy claims data do not include deductibles or any other physicianrelated service fees associated with administration of prolia® eg doctor visits oop costs may vary by patient andor injection data reflect ims formulary impact analyzer prolia® medicare part d claims n january  to september  data from commercial patients were not included in these analyses the cost information provided is for informational purposes only policies change periodically and often without warning if you have questions about oop costs contact the payer  of medicare part d beneficiaries have coverage for prolia® over half with no prior authorization pa required† prolia® has confirmed medical benefit coverage nationwide prolia® is covered by the following top† medicare part d plans aetnacoventry no pa required anthemblue cross blue shield affiliates  cignahealthspring no pa required‡ cvs caremarksilverscripthealth net no pa required express scripts pa may be required§ humana no pa required prime therapeuticsmedicareblue rxbluerx pa may be required¶ rite aidenvisionrx no pa required united healthcareaarpoptumrx  wellcare no pa required for the treatment in postmenopausal women with osteoporosis at high risk for fracture prescription drug plans covering  of part d beneficiaries include prolia® on their formularies policies for the remaining  of beneficiaries were not reviewed †plans are listed in alphabetical order list includes top plans based on covered lives that cover prolia® ‡plan requires an electronic step edit §some plans under express scripts may require a pa ¶medicareblue rx representing bcbs of mn mt ne nd and wy does not require a pa blue cross medicarerx representing bcbs of il nm ok and tx requires a pa other blue plans affiliated with prime therapeutics may or may not require a pa the coverage information provided is for informational purposes only and should in no way be considered a guarantee of coverage or reimbursement for any product or service policies change periodically and often without warning the responsibility to determine coverage and reimbursement parameters for a particular patient is always the responsibility of the provider or physician verify your patients insurance coverage with proliaplus® our support program can refer eligible medicare part b and medicare part d patients to independent copay foundations which may be able to provide financial assistance explore proliaplus® learn about financial assistance medicare provides coverage of dxa scans for women identified by a physician as estrogen deficient and at clinical risk of osteoporosis women and men with vertebral abnormalities indicative of osteoporosis and vertebral fracture women and men currently receiving an fdaapproved medication for osteoporosis commercial  oop cost with the prolia® copay card eligible patients with commercial insurance can pay  or less explore financial assistance commercially insured lives with medical benefit coverage for prolia®  have commercial coverage with policy language more restrictive than fdaapproved indication‡ approximately  of commercially insured prolia® patients did not require prior authorization data reflect insurance verifications n not actual claims for commercially insured patients submitted to and completed by proliaplus® in  plans may require that patient either fails or is intolerant to another osteoporosis medication please see planspecific requirements †based on analysis of coverage under the medical benefits of  us commercial plans for  million targeted commercial lives data as of february   ‡for example multiple bisphosphonate trials or limited inclusion criteria verify your patients insurance coverage with proliaplus® our support program can help verify patient coverage and outofpocket costs for prolia®—with results sent directly to your office explore proliaplus® learn about financial assistance × you are now leaving proliahcpcom you are now leaving proliahcpcom please know that the sponsors of this site are not responsible for content on the site you are about to enter please click here to continue 😳 you currently have javscript disabled this site is best viewed with javscript enabled 😳 reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states people cit group inc citn related topics stocksstock screenerfinancialsbanks overview news key developments people charts financials analysts research pulse citn on new york stock exchange usd pm edt change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  proia gina  ms gina m proia is executive vice president chief marketing and communications officer of the company she is responsible for overseeing the company’s branding marketing advertising communications and corporate citizenship strategies as well as ensuring they support cit’s strategic priorities she is also responsible for advancing strategies and programs to help promote a corporate culture that aligns employees with cit’s business goals facilitates sustained growth and complies with regulatory requirements proia joins cit following  years at ally financial where she served most recently as chief communications officer she has served as a board member of jumptart coalition a national nonprofit organization advancing financial education for young people she is also a member of the arthur w page society in  proia was recognized on pr week’s  under  list and in  she received the aiming high award from legal momentum the women’s legal defense and education fund which recognizes the accomplishments of women in business prior to joining ally proia held various positions at general motors in the areas of financial communications marketing communications and product publicity basic compensation total annual compensation  restricted stock awards  longterm incentive plans  all other  fiscal year total  options compensation   quantity market value exercisable   unexercisable   exercised   basic compensation name fiscal year total ellen alemany  carol hayles  george cashman  matthew galligan  james hudak  steven solk  as of   dec  » view all officers related topics stocksstock screenerfinancialsbanks gina proia cit group inc profile  biography  bloomberg feedback gina proia exec vpchief mktg  communications ofcr cit group inc website wwwcitcom corporate information address  cit drive livingston nj  united states phone  fax  web url wwwcitcom from the web sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data proia gina m  cit group insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsproia gina mcit group citevp  head of marketing not rankedproia gina ms performanceproia gina m has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked proia gina ms trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction datecitcit groupevp  head of marketinguninformative buymar  proia gina m has not reported any informative transactions for cit therefore performance cannot be measured track record datetransactionamountno of sharesprice per shareprofitform  mar   uninformative buy    na dec   uninformative buy    na see all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by insider trading  proia gina m  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  proia gina m select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana cit group inc cit proia gina mevp  head of marketing   direct view   secformcom all rights reserved archives        thu  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version gina m martin  buffalo ny  intelius sign in we found gina m martin in buffalo ny gina m martin intelius found that gina m martin is a female between  and  years old from buffalo ny we have connected them to  addresses  phones and  relatives or associates also known as gina m proia get report now age gina m martin is in her s gina has lived in buffalo ny berkshire ny niagara ny ginas relatives charles martin sam proia teresa proia w martin gina m martin zodiac signtaurus genderfemale professional status senior legal counsel at harris computer systems get report now want to know more about gina get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about gina or use our people search engine to find others get background check on gina m martin get a criminal check on gina m martin get a public record report on gina m martin get a people search report on gina m martin gina m martins contact information known cities lived in find out where gina m martin has lived as well as gina m martins phone numbers and email addresses gina m martin has lived in  states new york address for gina m martin  a s buffalo ny has lived in buffalo ny berkshire ny get full address report phone numbers associated with gina m martin    buffalo ny    buffalo ny    rochester ny get full phone report email addresses associated with gina m martin gncom get email report gina m martins education information known schools attended learn about gina m martins academic history find out which schools gina m martin attended the dates attended as well as the degrees gina m martin received the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act gina m martin has attended  schools cleveland state university  clevelandmarshall college of law  –  gina m martin has a jd in juris doctor cleveland state university  clevelandmarshall college of law  –  gina m martin has a jd juris doctor in juris doctor suny at buffalo  –  gina m martin has a ba in legal studies suny at buffalo  –  gina m martin has a ba in legal studies suny at buffalo  –  gina m martin has a ba legal studies in legal studies gina m martins professional information information regarding gina m martins professional history find out previous places gina m martin has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act gina m martin has worked at  places company harris computer systems title senior legal counsel company excellus  inc title senior legal counsel gina m martins experience title senior legal counsel company harris computer systems job details title senior legal counsel company excellus  inc job details additional professional information on gina m martin see gina m martins linkedin profile gina m martins social network and potential email matches find out potential social network profiles and potential email usernamed for gina m martin gina m martins known social networks and potential email matches find all of gina m martins social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches gina martin username matches ginamartin martingina ginamartin martingina ginamartin martingina ginamartin martingina gmartin popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches g martin intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here gina proias phone  address  peoplebyname contact login home people alphabetically p proia gina proia people directory with over  names record id gina proia middle stnewton ma age  born sep  background check  available record id gina proia albert stmiddletown ny background check  available record id gina proia salisbury rdnewton ma age  born sep  background check  available record id gina proia alberta drmiddletown ny  background check  available record id gina m proia summit rdkatonah ny age  born  background check  available record id gina m proia cynthia drbrockton ma age  born apr  background check  available record id gina m proia galen stwatertown ma age  born apr  background check  available record id gina m proia summit rdkatonah ny age  born  background check  available record id gina proia middle stnewton ma age  born sep  background check  available record id gina proia albert stmiddletown ny background check  available record id gina proia salisbury rdnewton ma age  born sep  background check  available record id gina proia alberta drmiddletown ny  background check  available record id gina m proia summit rdkatonah ny age  born  background check  available record id gina m proia summit rdkatonah ny age  born  background check  available record id gina m proia galen stwatertown ma age  born apr  background check  available record id gina m proia cynthia drbrockton ma age  born apr  background check  available record id gina proia middle stnewton ma age  born sep  background check  available record id gina proia albert stmiddletown ny background check  available record id gina proia salisbury rdnewton ma age  born sep  background check  available record id gina proia alberta drmiddletown ny  background check  available record id gina m proia summit rdkatonah ny age  born  background check  available record id gina m proia summit rdkatonah ny age  born  background check  available record id gina m proia galen stwatertown ma age  born apr  background check  available record id gina m proia cynthia drbrockton ma age  born apr  background check  available      total records available tweet testimonials read testimonials from real customers who already used our services read more webmasters earn  commission on every sale you drive to our website weekly payouts read more mobile version visit us from your smart phone anywhere you are read more recent lookups check out the most recent reverse phone lookups on peoplebynamecom read more home mobile version phone directory people directory remove information terms of service privacy policy affiliate program about us member login frequently asked questions contact us testimonials careers product  services volume discounts site map  peoplebyname all rights reserved  alongi v proia construction inc search advanced search take a free trial  sign in close law indepth law uk adv search  platform tools browse all sections banking bankruptcy class action competition employment energy expert analysis insurance intellectual property product liability securities rankings laws mvps glass ceiling report global  law  diversity snapshot practice group partner rankings practice groups of the year pro bono firms of the year rising stars trial aces site menu join the law team search legal jobs learn more about law read testimonials contact law sign up for our newsletters site map help february   alongi v proia construction inc track this case case number cv court massachusetts nature of suit labor erisa judge nathaniel m gorton view recent docket activity reflects complaints answers motions orders and trial notes entered from jan  additional or older documents may be available in pacer parties to view the parties register now try law free for seven days already a subscriber click here to login × already have access click here to login get instant access to the onestop news source for business lawyers register now get instant access to the onestop news source for business lawyers email professional email required first name last name please note a verification email will be sent to your address before you can access your trial password at least  characters required confirm password select at least one primary interest aerospace  defense appellate asset management automotive banking bankruptcy california capital markets class action commercial contracts competition consumer protection corporate cybersecurity  privacy delaware employment energy environmental financial services uk florida food  beverage government contracts health hospitality illinois immigration insurance insurance uk intellectual property international arbitration international trade law in depth legal ethics life sciences media  entertainment medical malpractice mergers  acquisitions native american new jersey new york pennsylvania private equity product liability project finance public policy real estate retail  e commerce securities sports tax technology telecommunications texas transportation trials white collar register already have access email password forgot your password remember login sign in gina proia avon ma  intelius  off  off  off special offer hey wait get the information you need with a background check for just   get the information you need with a people search for just   get the information you need with a phone report for just   get the information you need with a background check for just   get the information you need with a people search for just   get the information you need with a phone report for just   yes i want this offer no ill pass on this offer × menu intelius premier identity protect help sign in browser issue detected cookies must be enabled in order for you to use services however it seems that cookies are disabled in your browser to use services enable cookies by changing your browser options then try again show me how to enable cookies after you enable cookies please click here search results for gina proia in avon ma get a report on gina m proia in avon ma we found gina m proia address history avon ma hampton bays ny southampton ny richmond va brockton ma view more relatives jason rindfleisch carolyn proia paul proia james rindfleisch gina m proia  avon ma get a report on gina m proia get the information you need on gina m proia intelius reports include some or all of the following full name age  date of birth address address history phone numbers aliases relatives neighbors email addresses social networks property records marriage  divorce criminal records bankruptcies liens judgments lawsuits get a report gina m proia age  get full report on gina address history avon ma hampton bays ny southampton ny richmond va brockton ma quincy ma relatives jason rindfleisch carolyn proia paul proia james rindfleisch get a report intelius reports can include full name age  date of birth address address history phone numbers aliases relatives neighbors email addresses social networks property records marriage  divorce criminal records bankruptcies liens judgments lawsuits not the right person search again not the right person search again first name mi last name required city andor state search intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here × microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft prolia® denosumab × indications prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal read more prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal women with osteoporosis prolia® reduces the incidence of vertebral nonvertebral and hip fractures prolia® is indicated for treatment to increase bone mass in men with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy prolia® is indicated as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer in these patients prolia® also reduced the incidence of vertebral fractures prolia® is indicated as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer close prescribing information medication guide important safety information nonus residents for patients indications rems search postmenopausal osteoporosis male osteoporosis cancer treatment—induced bone loss how to get prolia® toggle menu menu postmenopausal osteoporosis pmo pmo overview patient identification treatment naive risk factors for fracture intolerant to other osteoporosis therapy failed other therapy prior fracture prevalence treatment prevalence vertebral fracture risk subsequent fracture risk hip fracture risk women over the age of  study design pivotal efficacy fracture risk reduction increase in bmd safety adverse reactions pivotal trial dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe male osteoporosis male op male osteoporosis male op overview patient identification risk factors among men assessment recommendations height loss prevalence risk assessment is rare osteoporosis prevalence study design pivotal efficacy lumbar spine bmd total hip bmd dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe cancer treatment–induced bone loss ctibl breast cancer treatment–induced bone loss ctibl overview bmd data ctiblhalt pivotal trial fracture reduction data abcsg study prostate cancer treatment–induced bone loss ctibl overview bmd and fracture reduction data pivotal trial if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe how to get prolia® how to get prolia® overview fulfillment options verify coverage financial assistance injection reminder coding and billing insurance coverage medicare part b cost medicare part b coverage medicare part d cost medicare part d coverage commercial coverage copay and financial assistance prolia® copay card medicaremedicaid referrals uninsuredunderinsured options support program insurance support treatment reminders financial assistance referral for ctiblhalt patients for ctiblhalt patients amgen assist ™ if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe helpful links  resources helpful links  resources amgen resources preferred distributors educational resources patient identification videos nonus residents important safety information for patients rems for the treatment of postmenopausal women with osteoporosis at high risk for fracture with  dose every  months prolia® follows your pmo patients all year long  mg subcutaneous injection in the upper arm upper thigh or abdomen by a healthcare professional preexisting hypocalcemia must be corrected prior to initiating therapy with prolia® adequately supplement all patients with calcium and vitamin d multiple vertebral fractures have been reported following prolia® discontinuation risk evaluation and mitigation strategy rems learn about coverage and multiple fulfillment solutions available for your prolia® patients how to get prolia®  i frequently get a sour taste in my mouth  i regularly feel a burning pain in my throat  i often get heartburn what are you hearing from your patients with pmo at high risk for fracture this image is for illustration purposes only patient types  if she had a prior fracture is she at risk of another fracture ask your pmo patients if they’ve had a prior osteoporotic fracture in women prior osteoporotic fracture increases the relative risk of a subsequent fracture by  this image is for illustration purposes only patient types falling excessive thinness cigarette smoking advanced age prior fracture as an adult parental history of hip fracture are there pmo patients with multiple risk factors for fracture in your practice  or more risk factors put your postmenopausal osteoporotic patients at high risk for fracture patient types tscore at therapy start  tscore at  years  tscore at  years  do you have pmo patients with a significant bmd decline despite osteoporosis therapy whom you consider a treatment failure this image is for illustration purposes only patient types  in  women over the age of  will have a fracture related to osteoporosis in their lifetime take a closer look at fracture risk and prevalence among women with postmenopausal osteoporosis prevalence for the treatment of postmenopausal women with osteoporosis at high risk for fracture prolia® is proven to significantly reduce fracture risk at  years at vertebral hip and nonvertebral sites in the pivotal phase  fracture trial vs placebo n   efficacy please see efficacy section for important study details prolia® was studied for  years in a pivotal phase  fracture trial of  women with postmenopausal osteoporosis study design important safety information clinically significant hypersensitivity including anaphylaxis has been reported with prolia® if an anaphylactic or other clinically significant allergic reaction occurs initiate appropriate therapy and discontinue prolia® prolia® denosumab safety profile learn about adverse reactions reported in women with pmo from the pivotal phase  fracture trial adverse reactions learn about the prolia® risk evaluation and mitigation strategy program rems learn about prolia® important safety information important safety information prolia® is  shot every  months singleuse prefilled  ml syringe  mg subcutaneous injection in the upper arm upper thigh or abdomen by a healthcare professional preexisting hypocalcemia must be corrected prior to initiating therapy with prolia® adequately supplement all patients with calcium and vitamin d multiple vertebral fractures have been reported following prolia® discontinuation as a subcutaneous injection prolia® does not undergo firstpass metabolism may lessen patient pill burden dosing important safety information following discontinuation of prolia® treatment fracture risk increases including the risk of multiple vertebral fractures evaluate an individual’s benefitrisk before initiating treatment with prolia® if prolia® treatment is discontinued consider transitioning to an alternative antiresorptive therapy see how prolia® works as the first fdaapproved rank ligand inhibitor for pmo patients at high risk for fracture learn more help your patients get prolia® prolia® has confirmed medical benefit coverage nationwide you can administer prolia® in your office or refer your patient to an injection center coverage × × you are now leaving proliahcpcom you are now leaving proliahcpcom please know that the sponsors of this site are not responsible for content on the site you are about to enter please click here to continue 😳 you currently have javscript disabled this site is best viewed with javscript enabled 😳 prolia® denosumab  insurance coverage × indications prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal read more prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal women with osteoporosis prolia® reduces the incidence of vertebral nonvertebral and hip fractures prolia® is indicated for treatment to increase bone mass in men with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy prolia® is indicated as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer in these patients prolia® also reduced the incidence of vertebral fractures prolia® is indicated as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer close prescribing information medication guide important safety information nonus residents for patients indications rems search postmenopausal osteoporosis male osteoporosis cancer treatment—induced bone loss how to get prolia® toggle menu menu postmenopausal osteoporosis pmo pmo overview patient identification treatment naive risk factors for fracture intolerant to other osteoporosis therapy failed other therapy prior fracture prevalence treatment prevalence vertebral fracture risk subsequent fracture risk hip fracture risk women over the age of  study design pivotal efficacy fracture risk reduction increase in bmd safety adverse reactions pivotal trial dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe male osteoporosis male op male osteoporosis male op overview patient identification risk factors among men assessment recommendations height loss prevalence risk assessment is rare osteoporosis prevalence study design pivotal efficacy lumbar spine bmd total hip bmd dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe cancer treatment–induced bone loss ctibl breast cancer treatment–induced bone loss ctibl overview bmd data ctiblhalt pivotal trial fracture reduction data abcsg study prostate cancer treatment–induced bone loss ctibl overview bmd and fracture reduction data pivotal trial if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe how to get prolia® how to get prolia® overview fulfillment options verify coverage financial assistance injection reminder coding and billing insurance coverage medicare part b cost medicare part b coverage medicare part d cost medicare part d coverage commercial coverage copay and financial assistance prolia® copay card medicaremedicaid referrals uninsuredunderinsured options support program insurance support treatment reminders financial assistance referral for ctiblhalt patients for ctiblhalt patients amgen assist ™ if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe helpful links  resources helpful links  resources amgen resources preferred distributors educational resources patient identification videos nonus residents important safety information for patients rems how to get prolia® coverage prolia® is broadly covered by medicare and commercial health plans nationwide†  coverage for medicare part b†  coverage for medicare part d†  coverage for commercial plans† please see planspecific requirements †medicare part b data as of february  medicare part d for the treatment in postmenopausal women with osteoporosis at high risk for fracture prescription drug plans covering  of part d beneficiaries include prolia® on their formularies policies for the remaining  of beneficiaries were not reviewed commercial based on analysis of coverage under the medical benefits of  us commercial plans for  million targeted commercial lives data as of february   medicare part b medicare part d commercial plans medicare part b  of prolia® syringes cost medicare part b patients  oop according to benefit verification data†‡ oop costs for medicare part b patients per prolia® syringe  of syringes these data do not include medical benefit oop costs related to office visits or administration of prolia® this sample includes medicare patients with supplementalsecondary coverage eg medigap that may require additional monthly premiums individual oop costs will vary data reflect insurance verifications for medicare part b patients only n   not actual claims completed by proliaplus® from january   to december   †oop costs identified in insurance verification data as a percentage eg coinsurance were converted to dollars using the medicare part b reimbursement rate for q  which was  ‡costs for patients covered by medicare part c medicare advantage vary by plan the cost information provided is for informational purposes only policies change periodically and often without warning if you have questions about oop costs contact the payer  of medicare part b beneficiaries have prolia® coverage with no prior authorization required all medicare administrative contractors cover prolia® there are no prior authorizations under medicare part b† pa may be required under medicare part c medicare advantage‡ prolia® has confirmed medical benefit coverage nationwide data as of february  †individual plans may request documentation to confirm administration is consistent with the prolia® label ‡ of patients covered by medicare part c medicare advantage plans require prior authorization data reflect insurance verifications for medicare part c medicare advantage patients n   not actual claims completed by proliaplus® from january   to december   verify your patients insurance coverage with proliaplus® our support program can refer eligible medicare part b and medicare part d patients to independent copay foundations which may be able to provide financial assistance explore proliaplus® learn about financial assistance medicare part d approximately  of prolia® syringes cost medicare part d patients no more than  out of pocket oop oop costs for medicare part d patients per prolia® syringe  of syringes for  of medicare part d patients with a copay less than  per syringe the approximate cost is  per month these pharmacy claims data do not include deductibles or any other physicianrelated service fees associated with administration of prolia® eg doctor visits oop costs may vary by patient andor injection data reflect ims formulary impact analyzer prolia® medicare part d claims n january  to september  data from commercial patients were not included in these analyses the cost information provided is for informational purposes only policies change periodically and often without warning if you have questions about oop costs contact the payer  of medicare part d beneficiaries have coverage for prolia® over half with no prior authorization pa required† prolia® has confirmed medical benefit coverage nationwide prolia® is covered by the following top† medicare part d plans aetnacoventry no pa required anthemblue cross blue shield affiliates  cignahealthspring no pa required‡ cvs caremarksilverscripthealth net no pa required express scripts pa may be required§ humana no pa required prime therapeuticsmedicareblue rxbluerx pa may be required¶ rite aidenvisionrx no pa required united healthcareaarpoptumrx  wellcare no pa required for the treatment in postmenopausal women with osteoporosis at high risk for fracture prescription drug plans covering  of part d beneficiaries include prolia® on their formularies policies for the remaining  of beneficiaries were not reviewed †plans are listed in alphabetical order list includes top plans based on covered lives that cover prolia® ‡plan requires an electronic step edit §some plans under express scripts may require a pa ¶medicareblue rx representing bcbs of mn mt ne nd and wy does not require a pa blue cross medicarerx representing bcbs of il nm ok and tx requires a pa other blue plans affiliated with prime therapeutics may or may not require a pa the coverage information provided is for informational purposes only and should in no way be considered a guarantee of coverage or reimbursement for any product or service policies change periodically and often without warning the responsibility to determine coverage and reimbursement parameters for a particular patient is always the responsibility of the provider or physician verify your patients insurance coverage with proliaplus® our support program can refer eligible medicare part b and medicare part d patients to independent copay foundations which may be able to provide financial assistance explore proliaplus® learn about financial assistance medicare provides coverage of dxa scans for women identified by a physician as estrogen deficient and at clinical risk of osteoporosis women and men with vertebral abnormalities indicative of osteoporosis and vertebral fracture women and men currently receiving an fdaapproved medication for osteoporosis commercial  oop cost with the prolia® copay card eligible patients with commercial insurance can pay  or less explore financial assistance commercially insured lives with medical benefit coverage for prolia®  have commercial coverage with policy language more restrictive than fdaapproved indication‡ approximately  of commercially insured prolia® patients did not require prior authorization data reflect insurance verifications n not actual claims for commercially insured patients submitted to and completed by proliaplus® in  plans may require that patient either fails or is intolerant to another osteoporosis medication please see planspecific requirements †based on analysis of coverage under the medical benefits of  us commercial plans for  million targeted commercial lives data as of february   ‡for example multiple bisphosphonate trials or limited inclusion criteria verify your patients insurance coverage with proliaplus® our support program can help verify patient coverage and outofpocket costs for prolia®—with results sent directly to your office explore proliaplus® learn about financial assistance × you are now leaving proliahcpcom you are now leaving proliahcpcom please know that the sponsors of this site are not responsible for content on the site you are about to enter please click here to continue 😳 you currently have javscript disabled this site is best viewed with javscript enabled 😳 how to get prolia® denosumab × indications prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal read more prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal women with osteoporosis prolia® reduces the incidence of vertebral nonvertebral and hip fractures prolia® is indicated for treatment to increase bone mass in men with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy prolia® is indicated as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer in these patients prolia® also reduced the incidence of vertebral fractures prolia® is indicated as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer close prescribing information medication guide important safety information nonus residents for patients indications rems search postmenopausal osteoporosis male osteoporosis cancer treatment—induced bone loss how to get prolia® toggle menu menu postmenopausal osteoporosis pmo pmo overview patient identification treatment naive risk factors for fracture intolerant to other osteoporosis therapy failed other therapy prior fracture prevalence treatment prevalence vertebral fracture risk subsequent fracture risk hip fracture risk women over the age of  study design pivotal efficacy fracture risk reduction increase in bmd safety adverse reactions pivotal trial dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa read more about icd and jcode information learn more male osteoporosis male op male osteoporosis male op overview patient identification risk factors among men assessment recommendations height loss prevalence risk assessment is rare osteoporosis prevalence study design pivotal efficacy lumbar spine bmd total hip bmd dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa read more about icd and jcode information learn more cancer treatment–induced bone loss ctibl breast cancer treatment–induced bone loss ctibl overview bmd data ctiblhalt pivotal trial fracture reduction data abcsg study prostate cancer treatment–induced bone loss ctibl overview bmd and fracture reduction data pivotal trial read more about icd and jcode information learn more how to get prolia® how to get prolia® overview fulfillment options verify coverage financial assistance injection reminder coding and billing insurance coverage medicare part b cost medicare part b coverage medicare part d cost medicare part d coverage commercial coverage copay and financial assistance prolia® copay card medicaremedicaid referrals uninsuredunderinsured options support program insurance support treatment reminders financial assistance referral for ctiblhalt patients for ctiblhalt patients amgen assist ™ read more about icd and jcode information learn more helpful links  resources helpful links  resources amgen resources preferred distributors educational resources patient identification videos nonus residents important safety information for patients rems coverage information and fullfillment options to help your patients get prolia®  medicare part b coverage  medicare part d coverage  commercial coverage choose your fulfillment channel below as the first step in deciding how to get prolia® medicare part b data as of february  medicare part d for the treatment in postmenopausal women with osteoporosis at high risk for fracture prescription drug plans covering  of part d beneficiaries include prolia® on their formularies policies for the remaining  of beneficiaries were not reviewed commercial based on analysis of coverage under the medical benefits of  us commercial plans for  million targeted commercial lives data as of february   learn about coverage and outofpocket costs for prolia® explore coverage choose how to help your patients get prolia® buy and bill for inoffice injections you can buy prolia® and deliver injections in your own office even for patients on medicare part b refer patients to injection sites you can refer your patients to a healthcare facility to receive their prolia® injection fill prescription through pharmacy specialty or retail pharmacies can fill prolia® prescriptions including those for patients with medicare part d read more about icd and jcode information below read more connect with preferred distributors to order prolia® for your office directly from one of our preferred distributors browse our helpful links page for a list of contact information and credit applications find preferred distributors verify your patients’ insurance coverage you can also learn how proliaplus® can help verify patient coverage and outofpocket costs for prolia® with results sent directly to your office explore insurance support explore prolia® injection network locations† to refer your patients to a healthcare facility to receive their prolia® injection you can explore our searchable prolia® injection network locations database explore injection networks verify your patients’ insurance coverage you can also learn how proliaplus® can help verify patient coverage and outofpocket costs for prolia® with results sent directly to your office explore insurance support †any listing of injection network sites is for informational purposes only and should not be considered a comprehensive list of all the sites in a particular area in addition use of a site identified on the list does not guarantee coverage or administration of prolia® and does not guarantee that a particular patient will be administered or covered for prolia® find a specialty or local pharmacy to connect patients with specialty or local retail pharmacies to fill their prolia® prescriptions explore our searchable pharmacy database find a pharmacy explore fulfillment through specialty pharmacies specialty pharmacies can provide coordinated delivery and services to help prolia® patients start and stay on therapy these additional services may include insurance coverage investigation and prior authorization process support next injection reminders and prescription refills some health plans require a specific specialty pharmacy to be used mandated specialty pharmacies see your patient’s plan for specific policies instructions and requirements download mandated specialty pharmacies learn how to help patients find support and explore their financial assistance options connect with patient support explore financial assistance schedule next injection appointments for prolia® patients in your office singleuse prefilled  ml syringe this image is for illustration purposes only and represents a snapshot in time actual dosing and duration of a particular patients therapy should be based upon the products approved labeling and the independent clinical decision of the provider schedule your patient’s injection appointments every  months and learn about treatment reminders for your patients and your practice learn about treatment reminders prolia® is administered as  shot every  months  mg subcutaneous injection in the upper arm upper thigh or abdomen by a healthcare professional preexisting hypocalcemia must be corrected prior to initiating therapy with prolia® adequately supplement all patients with calcium and vitamin d multiple vertebral fractures have been reported following prolia® discontinuation coding and billing information on average prolia® claims are paid by medicare within  days‡ the permanent jcode for prolia® for medicare claim processing j injection denosumab  mg icd codes some payers may require providers to include icdcm diagnosis codes on medical claims for prolia® learn about examples of icd codes that may be appropriate for your patients read more ‡based on analysis of  medicare claims from january  to october  for prolia® includes claims paid on the first submission any information is of general nature only and not intended to be directive or a guarantee of reimbursement coding billing and coverage policies change periodically and often without warning the responsibility to determine coverage and reimbursement parameters—and appropriate coding for a particular partient andor procedure—is always the responsibility of the provider or physician × you are now leaving proliahcpcom you are now leaving proliahcpcom please know that the sponsors of this site are not responsible for content on the site you are about to enter please click here to continue 😳 you currently have javscript disabled this site is best viewed with javscript enabled 😳 prolia® denosumab  insurance coverage × indications prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal read more prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy in postmenopausal women with osteoporosis prolia® reduces the incidence of vertebral nonvertebral and hip fractures prolia® is indicated for treatment to increase bone mass in men with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture or multiple risk factors for fracture or patients who have failed or are intolerant to other available osteoporosis therapy prolia® is indicated as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer in these patients prolia® also reduced the incidence of vertebral fractures prolia® is indicated as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer close prescribing information medication guide important safety information nonus residents for patients indications rems search postmenopausal osteoporosis male osteoporosis cancer treatment—induced bone loss how to get prolia® toggle menu menu postmenopausal osteoporosis pmo pmo overview patient identification treatment naive risk factors for fracture intolerant to other osteoporosis therapy failed other therapy prior fracture prevalence treatment prevalence vertebral fracture risk subsequent fracture risk hip fracture risk women over the age of  study design pivotal efficacy fracture risk reduction increase in bmd safety adverse reactions pivotal trial dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe male osteoporosis male op male osteoporosis male op overview patient identification risk factors among men assessment recommendations height loss prevalence risk assessment is rare osteoporosis prevalence study design pivotal efficacy lumbar spine bmd total hip bmd dosing  shot every  months next injection pkpd profile rank ligand mechanism of action moa if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe cancer treatment–induced bone loss ctibl breast cancer treatment–induced bone loss ctibl overview bmd data ctiblhalt pivotal trial fracture reduction data abcsg study prostate cancer treatment–induced bone loss ctibl overview bmd and fracture reduction data pivotal trial if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe how to get prolia® how to get prolia® overview fulfillment options verify coverage financial assistance injection reminder coding and billing insurance coverage medicare part b cost medicare part b coverage medicare part d cost medicare part d coverage commercial coverage copay and financial assistance prolia® copay card medicaremedicaid referrals uninsuredunderinsured options support program insurance support treatment reminders financial assistance referral for ctiblhalt patients for ctiblhalt patients amgen assist ™ if prolia® is clinically appropriate for patients in your practice learn how to get prolia® when ready to prescribe helpful links  resources helpful links  resources amgen resources preferred distributors educational resources patient identification videos nonus residents important safety information for patients rems how to get prolia® coverage prolia® is broadly covered by medicare and commercial health plans nationwide†  coverage for medicare part b†  coverage for medicare part d†  coverage for commercial plans† please see planspecific requirements †medicare part b data as of february  medicare part d for the treatment in postmenopausal women with osteoporosis at high risk for fracture prescription drug plans covering  of part d beneficiaries include prolia® on their formularies policies for the remaining  of beneficiaries were not reviewed commercial based on analysis of coverage under the medical benefits of  us commercial plans for  million targeted commercial lives data as of february   medicare part b medicare part d commercial plans medicare part b  of prolia® syringes cost medicare part b patients  oop according to benefit verification data†‡ oop costs for medicare part b patients per prolia® syringe  of syringes these data do not include medical benefit oop costs related to office visits or administration of prolia® this sample includes medicare patients with supplementalsecondary coverage eg medigap that may require additional monthly premiums individual oop costs will vary data reflect insurance verifications for medicare part b patients only n   not actual claims completed by proliaplus® from january   to december   †oop costs identified in insurance verification data as a percentage eg coinsurance were converted to dollars using the medicare part b reimbursement rate for q  which was  ‡costs for patients covered by medicare part c medicare advantage vary by plan the cost information provided is for informational purposes only policies change periodically and often without warning if you have questions about oop costs contact the payer  of medicare part b beneficiaries have prolia® coverage with no prior authorization required all medicare administrative contractors cover prolia® there are no prior authorizations under medicare part b† pa may be required under medicare part c medicare advantage‡ prolia® has confirmed medical benefit coverage nationwide data as of february  †individual plans may request documentation to confirm administration is consistent with the prolia® label ‡ of patients covered by medicare part c medicare advantage plans require prior authorization data reflect insurance verifications for medicare part c medicare advantage patients n   not actual claims completed by proliaplus® from january   to december   verify your patients insurance coverage with proliaplus® our support program can refer eligible medicare part b and medicare part d patients to independent copay foundations which may be able to provide financial assistance explore proliaplus® learn about financial assistance medicare part d approximately  of prolia® syringes cost medicare part d patients no more than  out of pocket oop oop costs for medicare part d patients per prolia® syringe  of syringes for  of medicare part d patients with a copay less than  per syringe the approximate cost is  per month these pharmacy claims data do not include deductibles or any other physicianrelated service fees associated with administration of prolia® eg doctor visits oop costs may vary by patient andor injection data reflect ims formulary impact analyzer prolia® medicare part d claims n january  to september  data from commercial patients were not included in these analyses the cost information provided is for informational purposes only policies change periodically and often without warning if you have questions about oop costs contact the payer  of medicare part d beneficiaries have coverage for prolia® over half with no prior authorization pa required† prolia® has confirmed medical benefit coverage nationwide prolia® is covered by the following top† medicare part d plans aetnacoventry no pa required anthemblue cross blue shield affiliates  cignahealthspring no pa required‡ cvs caremarksilverscripthealth net no pa required express scripts pa may be required§ humana no pa required prime therapeuticsmedicareblue rxbluerx pa may be required¶ rite aidenvisionrx no pa required united healthcareaarpoptumrx  wellcare no pa required for the treatment in postmenopausal women with osteoporosis at high risk for fracture prescription drug plans covering  of part d beneficiaries include prolia® on their formularies policies for the remaining  of beneficiaries were not reviewed †plans are listed in alphabetical order list includes top plans based on covered lives that cover prolia® ‡plan requires an electronic step edit §some plans under express scripts may require a pa ¶medicareblue rx representing bcbs of mn mt ne nd and wy does not require a pa blue cross medicarerx representing bcbs of il nm ok and tx requires a pa other blue plans affiliated with prime therapeutics may or may not require a pa the coverage information provided is for informational purposes only and should in no way be considered a guarantee of coverage or reimbursement for any product or service policies change periodically and often without warning the responsibility to determine coverage and reimbursement parameters for a particular patient is always the responsibility of the provider or physician verify your patients insurance coverage with proliaplus® our support program can refer eligible medicare part b and medicare part d patients to independent copay foundations which may be able to provide financial assistance explore proliaplus® learn about financial assistance medicare provides coverage of dxa scans for women identified by a physician as estrogen deficient and at clinical risk of osteoporosis women and men with vertebral abnormalities indicative of osteoporosis and vertebral fracture women and men currently receiving an fdaapproved medication for osteoporosis commercial  oop cost with the prolia® copay card eligible patients with commercial insurance can pay  or less explore financial assistance commercially insured lives with medical benefit coverage for prolia®  have commercial coverage with policy language more restrictive than fdaapproved indication‡ approximately  of commercially insured prolia® patients did not require prior authorization data reflect insurance verifications n not actual claims for commercially insured patients submitted to and completed by proliaplus® in  plans may require that patient either fails or is intolerant to another osteoporosis medication please see planspecific requirements †based on analysis of coverage under the medical benefits of  us commercial plans for  million targeted commercial lives data as of february   ‡for example multiple bisphosphonate trials or limited inclusion criteria verify your patients insurance coverage with proliaplus® our support program can help verify patient coverage and outofpocket costs for prolia®—with results sent directly to your office explore proliaplus® learn about financial assistance × you are now leaving proliahcpcom you are now leaving proliahcpcom please know that the sponsors of this site are not responsible for content on the site you are about to enter please click here to continue 😳 you currently have javscript disabled this site is best viewed with javscript enabled 😳 microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft loading your search results  peoplelookercom updating data on  live please help us narrow down your search all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming im not sure please enter a full name please help us narrow down your search first name please enter first name last name please enter last name search engine marketing sem  bing ads skip to content sign upsign in   you run your business well help find your customers bing ads can help build your business and drive your success spend  and get  in advertising credit† †offer details get  in search advertising when you spend  in bing ads coupon code class first name last name email your website url business phone required microsoft may contact you to provide updates and special offers about bing ads you can unsubscribe at any time to learn more you can read the privacy statement type the code from the image enter security code   × get  in search advertising when you spend  in bing ads †offer details offer expires december   valid only for new bing ads customers who are first party recipients of the offer email a new bing ads customer is one that has not advertised on bing ads before enter promotional coupon code and spend  applies to threshold and prepaid accounts to receive  in bing ads credits limit one promotion code per new bing ads customer promotional code must be redeemed within thirty  days of bing ads new customer account creation ad campaign costs accrued before receiving a credit as well as costs accrued after all credits are used will be charged to the payment method associated with the bing ads account if customer payment fails the coupon amount will not be applied ads will continue to run and accrue costs after any promotional credit has been used up any portion of the credit not used within ninety  days of credit redemption will expire and cant be carried over even if the bing ads customer switches their payment method offer valid only to residents of the united states in order for the offer to be valid a form of payment must be entered into your account prior to redemption of the promotional code and prior to your account going live to take advantage of the credit this offer may not be combined with any other offer promotional code coupon or discount separated redeemed for cash transferred sold or bartered microsoft in its sole discretion can close your account for any suspected coupon abuse refund of the  is not permitted see bing ads terms and conditions for more details at signup other terms and conditions may apply microsoft reserves the right to cancel change or suspend this offer at any time without notice see how bing ads works customers search customers see your ad customers contact you watch how bing ads works     × how bing ads works help more customers find you see how bing can attract customers your google adwords campaigns cant reach  million searchers on the bing network tap into  of the search marketplace get in front of searchers who spend  percent more than the average internet searcher powerful network powerful benefits reach across devicesconnect with customers looking for your business anytime anywhere on any device go global or localreach people in the bing network everywhere or focus on cities counties and areas within a certain distance from your business easy to importif youre already using another product like google adwords its easy to pull that campaign into bing ads you control your costs  free signupjoin bing ads for free and control your account at every step  only pay for clickspay just when customers click on your ad no click no charge  no minimum feestart advertising with a budget that works best for your business   the advantage we gain in cost per click gives us a great return on investment — more than  percent better than google adwords scott redgate search engine marketing manager — cj pony parts by using bing ads features like image extensions and sitelink extensions this auto parts retailer races to convert customers and beat its competition  read about driving more conversions   we might not get as much of the volume as with google adwords but the volume of the traffic that we get converts really well at a lower cost scott schult executive vice president of marketing — myrtle beach area convention and visitors bureau the myrtle beach area convention and visitors bureau uses bing ads to drive site traffic and tourism at lower cost  read about getting better roi better results for less cost thats as simple as i can make it if i look at the quality of the traffic we get for the dollars we spend on bing ads our roi is fantastic alex littlewood ceo   motoroso motoroso a market network for auto enthusiasts gets better results for less cost and reaches a highvalue audience with bing ads  read about attracting quality traffic   import your adwords campaigns save time by importing your google adwords campaigns into bing ads to get ads live quickly sign in with your microsoft account or create one to get started on bing ads from within the bing ads interface select the import from google adwords option enter your google adwords credentials and select the campaign you want to import preview your ad get found online with search engine marketing make the most of your marketing dollars and drive customers to your business see how bing ads can work for you get started today give us a few details about your business to create a bing ads account and get it up and running   sign up get started with bing ads signing up is always free faq is bing ads right for me is bing ads right for my business all types of businesses find value and success with bing ads whether youre focused on local calls and foot traffic or want to drive traffic to your website from across the country or around the world bing ads has solutions for you i already appear in search results for free why should i pay for advertising your current customers may search for your business by name aiming it easy to find you in search results but customers youve yet to reach are more likely searching for general terms that wouldnt necessarily bring up your business in search results advertising next to relevant bing search results puts your business front and center with interested customers you otherwise might not reach what is the difference between seo and sem which one is right for me search engine optimization seo is adjusting your website to improve your natural ranking in search results you cannot pay to improve your website ranking on bing or yahoo thus we often refer to these results and unpaid or organic search results clicks from seo are free but seo also requires technical expertise and involves some factors over which you have only limited control search engine marketing sem is paid advertising that appears next to or above unpaid or organic search results these paid ads are purchased through bing ads you pay for sem clicks but sem gives you more control over when your website appears on results pages and you decide how much you want to pay and you can measure which ads are working and quickly improve your results you dont have to choose between seo and sem you can do both if my time is limited should i still try bing ads yes call a bing ads specialist at and we’ll set up your first campaign for you for free we’ll give you tips on getting the most out of your ads and set you up for success we’re here to help about bing ads where does my ad appear your ads could appear on the top or to the right of bing yahoo and msn search results and you can choose to target your ads to different geographic regions times or days of the week and even demographics what determines my ad position bing ads is a payperclick ppc advertising system you bid based on how much you are willing to pay per each click on your ad because webpages have a limited number of places to show ads we auction those spaces you are bidding against other advertisers to get your ads into the space you want so if you bid on the keyword shoe you will have to beat the bids of the other advertisers who are also bidding on shoe you determine how much you are willing to bid your ad position is based on several things including how closely your ad and website fit with the terms that are searched relevance how your bid compares to other bids in the bing ads auction how strongly your ad has performed in the past and how often it has been clicked clickthrough rate the stronger you are in these areas the better your chances of winning the top ad position how to use bing ads how can i use bing ads to drive more people to my website here are some tips to get better results review your budget and bid strategy if your ad keeps pausing your budget limit may be set too low competitive bids help your ad stay in a strong position to catch eyes and get more clicks to your website expand your targeting both for location and for devices computer mobile and tablet make sure your ads and website are relevant to the keywords you bid on would someone searching your terms expect to see and ad for your business how can i keep my costs down while your first instinct may be to lower your budget first try lowering your maximum bids yes this could mean fewer customers visit your site but if you increase your quality score and build ads with a strong performance history you may be able to win a good ad position with a lower bid that would lower your costperclick and help stretch your budget how do i know if bing ads is working view a wide range of performance trends in your account to quickly see key stats ad clicks the number of times your ad appeared impressions spend average costperclick clickthrough rate average ad position cost per acquisition and conversions you can also run performance reports to get insights into how well your campaigns are doing can i run more than one ad yes in fact we encourage it only one ad will show at a time but running multiple ads lets you test different approaches to see whats working best with your target customers frequently businesses try out different ads for specific products or pages getting started with bing ads how do i get started sign up for bing ads which keywords should i choose you have a few options to help choose your keywords first youll want to think of the terms one of your customers might use to search for your products and offerings those search terms are a great starting point then you can use tools right in your account to find more keywords within bing ads click campaigns on the top of the page click the keywords tab and then click add keywords this will let you search for new keywords based on one you enter search a website for keywords search your destination urls for keywords how can i write a good ad here are a few tips that can help make your ad stand out keep your ads relevant one way to improve relevance is to use your customers most popular search terms in your ad titles and txt describe what sets your product apart use your customers language use words and writing tone that are likely to attract your typical customer be specific this clearer and more specific your offering the better for example rather than big discount specify and exact percentage such as  percent off give customers a reason to click your ad right now offer a specific call to action such as encouraging customers to request a brochure or consultation download a free ebook subscribe to a newsletter or take advantage of a limitedtime discount sign up with bing ads to get started